Slideshow

In This Issue: Volume 33, No. 3

Author(s):

Natalie Timoshin

Check out what's new in schizophrenia research, personality disorders, patient education, integrative psychiatry, addiction, and more.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
leaders
brain depression
nicotine use
brain schizophrenia
brain
Related Content
pills
January 16th 2025

Why We Need a New Class of Antidepressants

Aaron Koenig, MD
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
brain
January 15th 2025

Separating the Therapeutic From the Hallucinatory: A Look at a Novel Neuroplastogen for MDD

Aaron Koenig, MD
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
antipsychotics
January 14th 2025

Discontinuing Antipsychotics

Joshua Feder, MD, DFAPA Charmi Patel Rao, MD, DFAACAP
depression
January 14th 2025

New Phase 1 Data on DLX-001 for Patients With Major Depressive Disorder

Aaron Koenig, MD
© 2025 MJH Life Sciences

All rights reserved.